Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2025 04:03 ET | Source: Research and Markets

China's Licensing Trends Shaping Global Drug Development Analysis Report 2025: Parent Companies Benefitted from Upfront Payments for R&D, Gaining Equity in Novel Chinese Therapeutics

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "China's Licensing Trends Shaping Global Drug Development" report has been added to ResearchAndMarkets.com's offering.Over the past five years, China's...
December 02, 2025 09:12 ET | Source: Research and Markets

Anticancer Drug Market Share, Trends, Opportunities, and Forecasts, 2020-2024 & 2025-2030: Rising Global Cancer Incidence, Aging Populations, and Accelerating Therapeutic Research Advancements

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...
December 02, 2025 04:10 ET | Source: Research and Markets

Abemaciclib Research Report 2025: Eli Lilly and Company Dominates the $1.6 Billion Market - Long-term Forecasts to 2029 and 2034

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Abemaciclib Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The abemaciclib market size has grown rapidly in recent...
December 01, 2025 05:46 ET | Source: Research and Markets

Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts, 2035 - $13.98 Bn Market Expands as Demand for Oncology and Specialized Therapies Rises

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation,...
November 27, 2025 08:18 ET | Source: Research and Markets

IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline and Competitive Intelligence Report 2025: Oncology Applications Using Biomarker-driven Patient Stratification and Combination Treatments

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of IGF-1R- and IGF-1 Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
November 19, 2025 09:52 ET | Source: Research and Markets

Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Ewing Sarcoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 14, 2025 05:01 ET | Source: Research and Markets

STAT Inhibitors Pipeline Market Landscape Report 2025: Over 18 Companies and 22 Drugs in Various Stages of Development

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "STAT Inhibitors - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers an in-depth view of developments...
November 12, 2025 11:07 ET | Source: Research and Markets

U.S. Active Pharmaceutical Ingredients (API) Market Analysis 2025-2033 | Opportunities Driven by Rising Chronic Diseases, Expansion of Biologics and Biosimilars, and Enhanced Regulatory Oversight

Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "U.S. Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Type of Synthesis (Biotech, Synthetic), by Type of...
October 22, 2025 10:44 ET | Source: Research and Markets

T-Cell Malignancies Pipeline Research Report 2025: Market Opportunities with Over 75 Companies and 80+ Drugs, Exploring Novel Treatments Like CAR-T Therapies and Targeted Therapies

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Malignancies - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis of over 75...
October 09, 2025 08:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy

KNOXVILLE, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of independent preclinical...